PURPOSE: To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis. PC and glycerophosphocholine (GPC) are involved in phospholipid metabolism that accompanies mitosis. PC is the predominant peak in Grade 4 astrocytoma (GBM) while GPC dominates in AS2. MATERIALS AND METHODS: We used high resolution magic angle spinning magnetic resonance spectroscopy to compare the concentrations of 10 metabolites in 41 biopsies (16 AS2 and 25 AS3) from 24 tumors. Immunohistochemistry was performed on paired biopsies to determine the cell density, Ki-67 proliferation index, and vascular endothelial growth factor (VEGF) angiogenic marker expression. RESULTS: AS3 had higher PC than AS2; however, the PC:GPC was less than 1 in all cases irrespective of tumor grade. Within tumors, GPC increased with Ki-67 and PC and tCho increased with cell density. There was no association between any choline compound and VEGF. CONCLUSION: These data suggest that PC:GPC less than 1 is not unique to low grade glioma. Furthermore, the PC concentration that is a marker of aggressive glial tumors is not tightly linked to cell proliferation or angiogenesis in nonenhancing astrocytomas.
PURPOSE: To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis. PC and glycerophosphocholine (GPC) are involved in phospholipid metabolism that accompanies mitosis. PC is the predominant peak in Grade 4 astrocytoma (GBM) while GPC dominates in AS2. MATERIALS AND METHODS: We used high resolution magic angle spinning magnetic resonance spectroscopy to compare the concentrations of 10 metabolites in 41 biopsies (16 AS2 and 25 AS3) from 24 tumors. Immunohistochemistry was performed on paired biopsies to determine the cell density, Ki-67 proliferation index, and vascular endothelial growth factor (VEGF) angiogenic marker expression. RESULTS:AS3 had higher PC than AS2; however, the PC:GPC was less than 1 in all cases irrespective of tumor grade. Within tumors, GPC increased with Ki-67 and PC and tCho increased with cell density. There was no association between any choline compound and VEGF. CONCLUSION: These data suggest that PC:GPC less than 1 is not unique to low grade glioma. Furthermore, the PC concentration that is a marker of aggressive glial tumors is not tightly linked to cell proliferation or angiogenesis in nonenhancing astrocytomas.
Authors: Antonio C M Maia; Suzana M F Malheiros; Antonio J da Rocha; Carlos J da Silva; Alberto A Gabbai; Fernando A P Ferraz; João N Stávale Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825
Authors: J Sabatier; V Gilard; M Malet-Martino; J P Ranjeva; C Terral; S Breil; M B Delisle; C Manelfe; M Tremoulet; I Berry Journal: Invest Radiol Date: 1999-03 Impact factor: 6.016
Authors: Joonas A Haapasalo; Kristiina M Nordfors; Mika Hilvo; Immo J Rantala; Ylermi Soini; Anna-Kaisa Parkkila; Silvia Pastoreková; Jaromir Pastorek; Seppo M Parkkila; Hannu K Haapasalo Journal: Clin Cancer Res Date: 2006-01-15 Impact factor: 12.531
Authors: W G Negendank; R Sauter; T R Brown; J L Evelhoch; A Falini; E D Gotsis; A Heerschap; K Kamada; B C Lee; M M Mengeot; E Moser; K A Padavic-Shaller; J A Sanders; T A Spraggins; A E Stillman; B Terwey; T J Vogl; K Wicklow; R A Zimmerman Journal: J Neurosurg Date: 1996-03 Impact factor: 5.115
Authors: Christopher Dietz; Felix Ehret; Francesco Palmas; Lindsey A Vandergrift; Yanni Jiang; Vanessa Schmitt; Vera Dufner; Piet Habbel; Johannes Nowak; Leo L Cheng Journal: NMR Biomed Date: 2017-09-15 Impact factor: 4.044
Authors: Ramon F Barajas; Joanna J Phillips; Rupa Parvataneni; Annette Molinaro; Emma Essock-Burns; Gabriela Bourne; Andrew T Parsa; Manish K Aghi; Michael W McDermott; Mitchel S Berger; Soonmee Cha; Susan M Chang; Sarah J Nelson Journal: Neuro Oncol Date: 2012-06-18 Impact factor: 12.300
Authors: Sofie Van Cauter; Frederik De Keyzer; Diana M Sima; Anca Croitor Sava; Felice D'Arco; Jelle Veraart; Ronald R Peeters; Alexander Leemans; Stefaan Van Gool; Guido Wilms; Philippe Demaerel; Sabine Van Huffel; Stefan Sunaert; Uwe Himmelreich Journal: Neuro Oncol Date: 2014-07 Impact factor: 12.300
Authors: Rosemarie Marchan; Michaela S Lesjak; Joanna D Stewart; Roland Winter; Janine Seeliger; Jan G Hengstler Journal: Cell Cycle Date: 2012-10-31 Impact factor: 4.534